Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Industry Valuation for the Adult Vaccines Sector?

The market for adult vaccines has seen considerable growth in the past few years. It is predicted to rise from $22.82 billion in 2024 to $24.21 billion in 2025, with a compound annual growth rate (CAGR) of 6.1%. Factors contributing to this upward trend during the historic period include the rise in the elderly population, government-backed immunization initiatives, increasing knowledge of preventive health care, innovations in vaccine development, and public health awareness campaigns.

Expectations are high for the adult vaccines market to experience significant growth in the forthcoming years. By 2029, projections put the market size at $34.19 billion, representing a compound annual growth rate (CAGR) of 9.0%. The anticipated growth in this period is linked to several factors such as the rise of new infectious diseases, enhanced attention on immunization records, an increasing concern over antimicrobial resistance, worldwide initiatives toward pandemic readiness, a shift toward individualized vaccines, and heightened emphasis on maternal immunization. Noteworthy trends during this forecast period encompass the integration of digital health, technological progress in vaccine manufacturing, partnerships between government bodies and pharma corporations, advancements in vaccine delivery techniques, and the broadening of immunization programs.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9038&type=smp

What Forces Are Driving The Growth Of The Adult Vaccines Market?

The growth of the adult vaccine market is being propelled by the rising occurrence of infectious diseases. These illnesses, which transfer from one individual to another, can be effectively combated with vaccines, as they assist in building immunity against them. For example, the US-based national public health agency, the Centers for Disease Control and Prevention, reported 8,300 cases of tuberculosis in 2022, a rise from 7,874 cases in 2021. The incidence of TB slightly surged to 2.5 per 100,000 persons in 2022, up from 2.4 the previous year. Consequently, the escalating presence of infectious diseases is spurring the expansion of the adult vaccine market.

How Is The Adult Vaccines Industry Segmented Across Key Parameters?

The adult vaccines market covered in this report is segmented –

1) By Vaccine Type: Monovalent, Multivalent

2) By Technology: Live Attenuated Vaccines, Inactivated Viral Or Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines

3) By Application: Influenza, DPT, Human Papillomavirus, Zoster, Pneumococcal, Hepatitis

4) By End Users: Healthcare Firms, Hospitals

Subsegments:

1) By Monovalent: Single Antigen Vaccines, Specific Disease Vaccines

2) By Multivalent: Combination Vaccines, Multi-Antigen Vaccines

What Notable Trends Are Shaping The Direction Of The Adult Vaccines Market?

A prominent trend gaining traction in the adult vaccines market is the continual innovation of products by key companies, reaffirming their market positions. An example of this can be seen in the effort by GSK, a biopharma company from the UK, and IQVIA, a global provider of advanced analytics, technological solutions, and clinical research services based in India. These companies co-launched a platform known as Vaccine Track in August 2022. This platform is aimed at boosting adult vaccination rates across communities at a national level by regularly supplying pertinent data about trends. This enables a refined focus on and an improvement in public health initiatives.

Which Companies Currently Dominate The Competitive Landscape In The Adult Vaccines Industry?

Major companies operating in the adult vaccines market include GlaxoSmithKline PLC, Merck & Co, Sanofi Pasteur, Pfizer Inc, Commonwealth Serum Laboratories Limited, Johnson & Johnson, Serum Institute of India, AstraZeneca PLC, Novartis AG, Protein Sciences Corporation, Emergent BioSolutions Inc., Bavarian Nordic A/S, Dynavax Technologies Corporation, Novavax Inc, Medimmune LLC, BioNTech SE, Moderna, Inovio Pharmaceuticals, Sinovac, Valneva Se, Biological E Limited, Panacea Biotec, Shenzhen Kangtai Biological Products, Beijing Tiantan Biological Products, Hualan Biological Engineering, Chengdu Institute of Biological Products, Bharat Biotech International Limited, Takeda Pharmaceutical Company Limited

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/adult-vaccines-global-market-report

Which Geographic Regions Are Driving Demand In The Adult Vaccines Market?

North America was the largest region in the adult vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the adult vaccines market during the forecast period. The regions covered in the adult vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9038&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model